Sapphiros won a $12.4 million award from HHS BARDA to develop its molecular diagnostics platform for rapid detection of biothreats and emerging infectious diseases. The company plans to use the funding over 24 months to advance point-of-care and decentralized testing, with a single-use capillary blood collection system developed by Satio.